Skip to content

Category: General

Ophthotech Launching Human Study of Emerging Therapy for Stargardt Disease

Source: Foundation Fighting Blindness Blog – Eye on the Cure – Ophthotech Launching Human Study of Emerging Therapy for Stargardt Disease Audio Version:Your browser does not support the audio element. Ophthotech, a biopharmaceutical company developing therapies for eye diseases, has enrolled the first patient in its Phase 2b clinical…

Email this to someoneTweet about this on TwitterShare on FacebookShare on Google+Pin on Pinterest

Clinical Trial to Launch for System Combining Optogenetics and Eyewear

Source: Foundation Fighting Blindness Blog – Eye on the Cure – Clinical Trial to Launch for System Combining Optogenetics and Eyewear Audio Version:Your browser does not support the audio element. The French biotech GenSight Biologics has received regulatory authorization in the UK to launch the PIONEER Phase 1/2 clinical…

Email this to someoneTweet about this on TwitterShare on FacebookShare on Google+Pin on Pinterest

jCyte Reports Results for Phase 1/2a Clinical Trial for Retinal-Cell Treatment

Source: Foundation Fighting Blindness Blog – Eye on the Cure – jCyte Reports Results for Phase 1/2a Clinical Trial for Retinal-Cell Treatment A retinal-cell treatment for people with retinitis pigmentosa (RP) has performed encouragingly in a Phase 1/2a clinical trial. Developed by jCyte, the treatment was evaluated for 12…

Email this to someoneTweet about this on TwitterShare on FacebookShare on Google+Pin on Pinterest

History Is Made: FDA Approves Spark’s Vision-Restoring Gene Therapy

Source: Foundation Fighting Blindness Blog – Eye on the Cure – History Is Made: FDA Approves Spark’s Vision-Restoring Gene Therapy Spark Therapeutics’ vision-restoring RPE65 gene therapy has received marketing approval from the U.S. Food and Drug Administration, becoming the first gene therapy to gain regulatory approval in the U.S.…

Email this to someoneTweet about this on TwitterShare on FacebookShare on Google+Pin on Pinterest